Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
ANDHealth Secures Funding to Continue its Transformative CHICC Commercialization Program for a Further Two Years
ANDHealth, Australia’s leading digital and connected health commercialisation organisation, will continue the Victorian Connected Health Innovation and Commercialisation Capability (CHICC) program for a further two years thanks to funding from the Victorian State Government, following significant growth in the local sector since the program’s inception.
CHICC is a collaborative partnership between ANDHealth and the Victorian Government Department of Jobs, Skills, Industry and Regions (DJSIR) that was first established in 2022.
Under the new agreement, ANDHealth will continue to develop and strengthen Victoria’s digital and connected health technology sector through the CHICC program – contributing to the triple aim of economic growth, advanced manufacturing capabilities and health system resilience.
The agreement also aligns with ANDHealth’s new collaboration with the Aikenhead Centre for Medical Discovery (ACMD)…
Full release here, originally announced December 4th, 2025.
Lin Health Raises $11 Million Series A to Fuel Growth of Virtual Chronic Pain Recovery Platform
Lin Health, the leader in behavioral care for chronic pain recovery, today announced the close of an oversubscribed $11 million Series A financing round. The round was led by Proofpoint Capital, a U.S.-based venture firm formed by seasoned healthcare operators, with participation from new investors Osage Venture Partners and NewHealth Ventures. Continued strong support and investment came from existing investors, including aMoon, Mayo Clinic, Saban Ventures, Shoni Health Ventures, and Viola Ventures.
In partnership with major health systems, clinics, and payers, Lin Health is redefining chronic pain care to treat conditions as diverse as migraines, irritable bowel syndrome (IBS), and back and joint pain. Accessible to more than 60 million covered Americans, Lin offers patients an effective, non-opioid treatment that addresses the root cause of pain in the nervous system. Through a physician-led, coach-supported virtual program, Lin engages patients multiple times per week as a high-touch resource grounded in decades of clinical research and aligned with national guidelines for chronic pain management.
“This milestone reflects the confidence of our investors and the urgency of addressing our growing chronic pain crisis, as at least one in five doctor visits are tied to pain,” said Lin Health CEO and Co-Founder Yehuda Kogan. “We’ve proven that our mission-driven team and model deliver results for patients, systems, and payers, and now we’re ready to compound our rapid growth, scale our partnerships, and bring relief to the millions of underserved Americans living with these conditions.”
The company operates with a proven collaborative care model, leveraging its technology and AI software to scale operations and support patients and clinicians efficiently without increasing administrative costs, while deepening integration across the healthcare ecosystem…
Full release here, originally announced December 9th, 2025.
Announcing Automate.clinic’s Latest Funding Round
We’re excited to announce that Automate.clinic has closed a pre-seed round led by Matchstick Ventures and Headwater Ventures. Over the past several months, we’ve been building our platform, growing our team, and assembling a network of physicians ready to help train the next generation of healthcare AI.
The Shift to Domain Expertise
The most capable foundation models were built by consuming the world’s information—billions of web pages, books, and code repositories—then refined through feedback from generalist human trainers. That approach worked remarkably well for getting models to the impressive accuracy we see today.
But 63% isn’t good enough for healthcare.
The next wave of AI improvement requires domain experts. Not generalists labeling data, but experienced experts who understand the nuances of clinical reasoning, diagnostic uncertainty, and the messy realities of practicing medicine. As Mercor demonstrated by becoming the fastest-growing company in history—reaching $500 million in revenue in just 17 months—there’s a firehose of demand for expert training data and evaluation.
Healthcare, however, is a different beast…
Full release here, originally announced December 11th, 2025.
No comments:
Post a Comment